Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.
Amador Bioscience has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Amador Bioscience's investors include Sequoia Capital, MSA Capital, GL Ventures LLC, CMB International Capital Corporation, Cowin Venture.
Amador Bioscience is headquartered in Pleasanton, United States.
Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.
Amador Bioscience is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amador Bioscience — Funding & Investors." VCBacked, December 30, 2021, https://www.vcbacked.co/company/amador-bioscience. Accessed September 14, 2026.
VCBacked. (2021). Amador Bioscience — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/amador-bioscience
{{cite web |title=Amador Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/amador-bioscience |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated